
Alcidion grows contracted revenue to $50M
Key points
- Alcidion Group reported $50.0 million in FY27 contracted revenue as of Sept. 30, marking a 38% increase compared to the prior corresponding period.
- The company’s stock rose 15% to $0.12 following the quarterly trading update.
- Growth was driven by an expanded $7.5 million contract in the United Kingdom and the release of new software features.
Alcidion Group (ASX:ALC) released a year-to-date trading update showing contracted revenue reached $50 million by late September.
The figure represents a 38% gain over the prior corresponding period, up from the $44.9 million in contracted revenue reported at the end of June.
"The expanded number of hospitals at NCA gives us a significant footprint in one of the larger NHS trusts, and we see further opportunity for Miya to add value over time," said Alcidion Group Managing Director Kate Quirke.
The company expanded its contract with Northern Care Alliance NHS Foundation Trust to $7.5 million over 3 years, with $4.5 million expected to be recognised in FY27.
Following the announcement, the Alcidion Group share price was up at $0.12.
The business extended its hospital management offerings by launching Miya Patient Administration, a modern platform designed to handle operational administrative tasks.
In addition, the management team reconfirmed full-year financial guidance, expecting total revenue and underlying profit before tax and depreciation to exceed previous full-year levels.
Frequently asked questions
More from Australia
Star Entertainment shares rebound on WhiteHawk talks
Fluence delivers $4.7 million EBITDA for 2026
Champion Iron reports $404M quarterly revenues
CAR Group buys majority stake in Brazil's Auto Avaliar
Ingenia Communities rejects media third suitor speculation
Wiluna Mining starts drilling campaign at Wiluna Northwest